Why are mineralocorticoid receptor antagonists cardioprotective?

Por Chai, Wenxia, Danser, A. H. Jan
Publicado em 2006

Juxtaglomerular Cell Phenotypic Plasticity

Por Martini, Alexandre Góes, Danser, A. H. Jan
Publicado no High Blood Press Cardiovasc Prev (2017)

Is there an internal cardiac renin-angiotensin system?

Por Danser, A H Jan, Schalekamp, Maarten A D H
Publicado em 1996

β Adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics

Por Holmer, S, Hense, H, Danser, A, Mayer, B, Riegger, G, Schunkert, H
Publicado em 1998

The (pro)renin receptor. A decade of research: what have we learned?

Por Krop, Manne, Lu, Xifeng, Danser, A.H. Jan, Meima, Marcel E.
Publicado em 2012

Renal Angiotensin-Converting Enzyme Upregulation: A Prerequisite for Nitric Oxide Synthase Inhibition–Induced Hypertension?

Por Roksnoer, Lodi C.W., Hoorn, Ewout J., Danser, A.H. Jan
Publicado no J Am Soc Nephrol (2014)

L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition

Por Danser, A H Jan, Tom, Beril, de Vries, René, Saxena, Pramod R
Publicado em 2000

Response to “Is High Prorenin Level Related to Relative Aldosterone Excess?”

Por Tu, Wanzhu, Eckert, George J., Pratt, J. Howard, Danser, A.H. Jan
Publicado no Am J Hypertens (2013)

Modulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90

Por Filipeanu, Catalin M., de Vries, René, Danser, A.H. Jan, Kapusta, Daniel R.
Publicado em 2010

From ARB to ARNI in Cardiovascular Control

Por Uijl, Estrellita, Roksnoer, Lodi C. W., Hoorn, Ewout J., Danser, A. H. Jan
Publicado no Curr Hypertens Rep (2016)

Bradykinin potentiation by ACE inhibitors: a matter of metabolism

Por Tom, Beril, Dendorfer, Andreas, Vries, René de, Saxena, Pramod R, Jan Danser, A H
Publicado em 2002

Prorenin anno 2008

Por Danser, A. H. Jan, Batenburg, Wendy W., van Esch, Joep H. M., Krop, Manne
Publicado em 2008

Measurements of 17β-estradiol levels in mice for migraine research

Por Chan, K, Labruijere, S, Garrelds, I, Danser, A, Villalón, C, MaassenVanDenBrink, A
Publicado em 2013

The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

Por Saleh, Langeza, Verdonk, Koen, Visser, Willy, van den Meiracker, Anton H., Danser, A. H. Jan
Publicado no Ther Adv Cardiovasc Dis (2016)

Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.

Por Schunkert, H., Hense, H. W., Muscholl, M., Luchner, A., Kürzinger, S., Danser, A. H., Riegger, G. A.
Publicado em 1997

Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis

Por Jansen, Pieter M., Verdonk, Koen, Imholz, Ben P., Jan Danser, A. H., van den Meiracker, Anton H.
Publicado em 2011

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (...

Por Brugts, J. J., de Maat, M. P. M., Danser, A. H. J., Boersma, E., Simoons, M. L.
Publicado em 2011

Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus: a need for higher doses in diabetics?

Por Hollenberg, Norman K., Fisher, Naomi DL, Nussberger, Juerg, Moukarbel, George V., Barkoudah, Ebrahim, Danser, A.H. Jan
Publicado no J Hypertens (2011)

Recent advances in hypertension and cardiovascular toxicities with vascular endothelial growth factor (VEGF) inhibition

Por Touyz, Rhian M, Lang, Ninian N, Herrmann, Joerg, van den Meiracker, Anton H, Jan Danser, A. H.
Publicado no Hypertension (2017)

Vasoconstriction is determined by interstitial rather than circulating angiotensin II

Por Schuijt, Martin P, de Vries, René, Saxena, Pramod R, Schalekamp, Maarten A D H, Danser, A H Jan
Publicado em 2002